Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Fish and Richardson

Generated: October 24, 2017

DrugPatentWatch Database Preview

Details for Patent: 4,585,790

« Back to Dashboard

Summary for Patent: 4,585,790

Title: Pharmaceutical compositions
Abstract:Aqueous formulations of raniditine have been found to have enhanced shelf life provided that they are formulated with a pH in the range 6.5--7.5. Suitable aqueous formulations include injections for intravenous and intramuscular administration, continuous infusions and oral preparations such as syrups.
Inventor(s): Padfield; John M. (Meldreth, GB2), Winterborn; Ian K. (Stevenage, GB2)
Assignee: Glaxo Group Limited (London, GB2)
Application Number:06/609,215
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation; Dosage form; Process;

No matches for this query

Foreign Priority and PCT Information for Patent: 4,585,790

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom83 13217May 13, 1983

International Patent Family for Patent: 4,585,790

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2792984► Subscribe
Australia568647► Subscribe
Belgium899635► Subscribe
Canada1216240► Subscribe
Switzerland662272► Subscribe
Czechoslovakia9104036► Subscribe
Czech Republic281598► Subscribe
Germany3417606► Subscribe
Denmark165663► Subscribe
Denmark237884► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

Google Plus